Status of research on antihypertensive drugs
10.13699/j.cnki.1001-6821.2017.24.020
- VernacularTitle:抗高血压药物的研究现状
- Author:
Gai-Yan WEN
1
;
Hong YUAN
;
Jing-Xian SHU
;
Jia ZHONG
;
Ruifang CHEN
;
Ying LI
;
Li-Hua HUANG
;
Zhi-Jun HUANG
;
Xiao-Wei XING
;
Yao LU
Author Information
1. 浙江医院药剂科,杭州310000
- Keywords:
hypertension;
anti-hypertensive drug;
cardiovascular disease
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(24):2629-2632
- CountryChina
- Language:Chinese
-
Abstract:
Hypertension is the leading risk factor for death resulted from cardiovascular diseases.According to the statistics,the number of patients with hypertension in China is 270 million.At present,15 classes and 69 drugs have been approved for the treatment of hypertension,however,the treatment rate and the control rate remain low.Therefore,the research tocusing on new antihypertensive drugs are how to effectively reduce the blood pressure in patients with refractory hypertension,reduce the target organ damage in patients with complications,and reduce adverse drug reactions.This paper summarized the recent research progress of anti-hypertensive drugs on the market or in development,so as to provide references for development and application of antihypertensive drugs.
